Organization · Venture Capital
Saisei Ventures
Saisei Ventures is an early-stage venture capital firm specializing in the Japanese biotech ecosystem, focusing on advanced therapeutic platforms and bridging local innovation with global expertise.
Overview
What Saisei Ventures does
What Saisei Ventures is
Saisei Ventures is an early-stage venture capital firm specializing in the Japanese biotech ecosystem, focusing on advanced therapeutic platforms and bridging local innovation with global expertise.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Saisei Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Saisei Ventures as a funder
Investment thesis
Saisei Ventures aims to grow and harness Japan's biotech ecosystem by combining Western expertise with Japanese innovation to build globally competitive companies focused on improving patient health outcomes through advanced therapeutic platforms.
Focus narrative
Saisei Ventures specializes in the life sciences sector, particularly in advanced therapeutic platforms such as cell immunotherapies, pluripotent cell replacement therapies, and gene therapy approaches. The firm supports programs with a clear path to clinical and commercial scale manufacturing, addressing serious diseases while leveraging the Japanese ecosystem and global technology sourcing.
Value beyond capital
Saisei Ventures adds value to its portfolio companies through a hands-on approach, actively participating in company creation and leveraging its extensive network to bridge Japanese scientific innovation with Western biotech expertise and capital markets.
Focus and fit
- Stages
- Seed · Series A
- Regions
- CanadaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Saisei Ventures partners with innovative ventures in the biotech space, including notable companies such as Craif, which focuses on nanowire-based liquid biopsy for cancer detection; CureApp, offering evidence-based digital therapeutics; and Kenai Therapeutics, which develops iPSC-derived neuron replacements for Parkinson's disease.
Common questions
What to know about Saisei Ventures
Upseed classifies Saisei Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.